20-10216813-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000451151.7(SNAP25-AS1):​n.301+2424T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 151,468 control chromosomes in the GnomAD database, including 20,672 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 20672 hom., cov: 29)

Consequence

SNAP25-AS1
ENST00000451151.7 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.26

Publications

9 publications found
Variant links:
Genes affected
SNAP25-AS1 (HGNC:44312): (SNAP25 antisense RNA 1)
SNAP25 (HGNC:11132): (synaptosome associated protein 25) Synaptic vesicle membrane docking and fusion is mediated by SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) located on the vesicle membrane (v-SNAREs) and the target membrane (t-SNAREs). The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices, one of which is supplied by v-SNARE and the other three by t-SNARE. For t-SNAREs on the plasma membrane, the protein syntaxin supplies one helix and the protein encoded by this gene contributes the other two. Therefore, this gene product is a presynaptic plasma membrane protein involved in the regulation of neurotransmitter release. Two alternative transcript variants encoding different protein isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
SNAP25 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
  • congenital myasthenic syndrome 18
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000451151.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000451151.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNAP25-AS1
NR_040710.1
n.270+2424T>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SNAP25-AS1
ENST00000421143.7
TSL:5
n.133-19876T>A
intron
N/A
SNAP25-AS1
ENST00000426491.5
TSL:5
n.270+2424T>A
intron
N/A
SNAP25-AS1
ENST00000451151.7
TSL:2
n.301+2424T>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.513
AC:
77711
AN:
151350
Hom.:
20663
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.353
Gnomad AMI
AF:
0.553
Gnomad AMR
AF:
0.631
Gnomad ASJ
AF:
0.620
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.540
Gnomad FIN
AF:
0.583
Gnomad MID
AF:
0.576
Gnomad NFE
AF:
0.564
Gnomad OTH
AF:
0.559
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.513
AC:
77745
AN:
151468
Hom.:
20672
Cov.:
29
AF XY:
0.518
AC XY:
38304
AN XY:
73966
show subpopulations
African (AFR)
AF:
0.353
AC:
14538
AN:
41234
American (AMR)
AF:
0.631
AC:
9606
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.620
AC:
2151
AN:
3468
East Asian (EAS)
AF:
0.520
AC:
2666
AN:
5128
South Asian (SAS)
AF:
0.539
AC:
2577
AN:
4784
European-Finnish (FIN)
AF:
0.583
AC:
6087
AN:
10440
Middle Eastern (MID)
AF:
0.582
AC:
171
AN:
294
European-Non Finnish (NFE)
AF:
0.564
AC:
38268
AN:
67894
Other (OTH)
AF:
0.560
AC:
1181
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1804
3607
5411
7214
9018
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
692
1384
2076
2768
3460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.530
Hom.:
2714
Bravo
AF:
0.513
Asia WGS
AF:
0.542
AC:
1883
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.8
DANN
Benign
0.79
PhyloP100
1.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6077690;
hg19: chr20-10197461;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.